Technical Analysis for FREQ - Frequency Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Historical FREQ trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Spinning Top | Other | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Fell Below 20 DMA | Bearish | -0.73% | |
| Multiple of Ten Bearish | Other | -0.73% | |
| Wide Bands | Range Expansion | -0.73% | |
| Crossed Above 20 DMA | Bullish | -6.05% | |
| Wide Bands | Range Expansion | -6.05% | |
| Fell Below 20 DMA | Bearish | 1.40% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Down 3% | about 18 hours ago | |
| Down 2 % | about 18 hours ago | |
| Down 1% | about 18 hours ago | |
| Fell Below Previous Day's Low | about 18 hours ago | |
| 20 DMA Resistance | about 18 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Frequency Therapeutics is a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Frequency’s progenitor cell activation (PCA) approach stimulates progenitor cells to create functional tissue with the aim of developing disease modifying therapeutics. The company’s lead product candidate, FX-322, is in clinical development and is designed to regenerate auditory hair cells to restore hearing function in patients with sensorineural hearing loss, the most common form of hearing loss. The company is also evaluating its PCA approach in additional diseases, including multiple sclerosis.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Clinical Development Disease Occupational Safety And Health Hearing Multiple Sclerosis Degenerative Disease Degenerative Diseases Perception Audiology Hearing Loss Progenitor Cell Deafness Auditory System Sensorineural Hearing Loss Hair Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biology Clinical Development Disease Occupational Safety And Health Hearing Multiple Sclerosis Degenerative Disease Degenerative Diseases Perception Audiology Hearing Loss Progenitor Cell Deafness Auditory System Sensorineural Hearing Loss Hair Cell
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 58.33 |
| 52 Week Low | 14.5 |
| Average Volume | 298,422 |
| 200-Day Moving Average | 27.07 |
| 50-Day Moving Average | 41.87 |
| 20-Day Moving Average | 50.57 |
| 10-Day Moving Average | 52.29 |
| Average True Range | 4.26 |
| ADX | 44.6 |
| +DI | 21.29 |
| -DI | 18.50 |
| Chandelier Exit (Long, 3 ATRs ) | 45.55 |
| Chandelier Exit (Short, 3 ATRs ) | 50.70 |
| Upper Bollinger Band | 58.18 |
| Lower Bollinger Band | 42.96 |
| Percent B (%b) | 0.41 |
| BandWidth | 30.10 |
| MACD Line | 2.87 |
| MACD Signal Line | 3.78 |
| MACD Histogram | -0.9099 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 57.04 | ||||
| Resistance 3 (R3) | 57.25 | 54.85 | 55.73 | ||
| Resistance 2 (R2) | 54.85 | 52.86 | 54.74 | 55.30 | |
| Resistance 1 (R1) | 52.03 | 51.62 | 50.83 | 51.82 | 54.86 |
| Pivot Point | 49.63 | 49.63 | 49.03 | 49.52 | 49.63 |
| Support 1 (S1) | 46.81 | 47.64 | 45.61 | 46.60 | 43.56 |
| Support 2 (S2) | 44.41 | 46.40 | 44.31 | 43.12 | |
| Support 3 (S3) | 41.59 | 44.41 | 42.69 | ||
| Support 4 (S4) | 41.38 |
